Voydeya

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 25682-046
  • Package NDC 25682-046-92
  • Application number NDA218037
  • SPL ID cd0113b0-d5d6-4b03-9f6f-4d80bdcb71fe
  • SPL set ID ab8d1cbd-a28b-4d49-82ab-5c7460719ac7
  • UNII JM8C1SFX0U
  • RxCUI 2678957
  • RxCUI 2678963
  • RxCUI 2678965
  • RxCUI 2678967
  • RxCUI 2678972
  • RxCUI 2678973
  • RxCUI 2678974
  • RxCUI 2678975

What the source publishes

Labeler
Alexion Pharmaceuticals Inc.
Active ingredients
Danicopan
Form
KIT
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:25682-046_cd0113b0-d5d6-4b03-9f6f-4d80bdcb71fe
{
  "name": "Voydeya",
  "splId": "cd0113b0-d5d6-4b03-9f6f-4d80bdcb71fe",
  "labels": [
    {
      "setId": "ab8d1cbd-a28b-4d49-82ab-5c7460719ac7",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ab8d1cbd-a28b-4d49-82ab-5c7460719ac7",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ab8d1cbd-a28b-4d49-82ab-5c7460719ac7"
    }
  ],
  "routes": [],
  "labeler": "Alexion Pharmaceuticals Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 KIT in 1 CARTON (25682-046-92)  *  90 TABLET, FILM COATED in 1 BOTTLE (25682-040-90)  *  90 TABLET, FILM COATED in 1 BOTTLE (25682-043-90)",
      "package_ndc": "25682-046-92",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20240329"
    }
  ],
  "productId": "25682-046_cd0113b0-d5d6-4b03-9f6f-4d80bdcb71fe",
  "useDomain": "unknown",
  "dosageForm": "KIT",
  "productNdc": "25682-046",
  "deaSchedule": null,
  "genericName": "Danicopan",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [],
  "applicationNumber": "NDA218037",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20240329",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000194113",
      "N0000194114",
      "N0000185503",
      "N0000190113"
    ],
    "unii": [
      "JM8C1SFX0U"
    ],
    "rxcui": [
      "2678957",
      "2678963",
      "2678965",
      "2678967",
      "2678972",
      "2678973",
      "2678974",
      "2678975"
    ],
    "spl_set_id": [
      "ab8d1cbd-a28b-4d49-82ab-5c7460719ac7"
    ],
    "pharm_class_epc": [
      "Complement Factor D Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
      "Complement Factor D Inhibitors [MoA]",
      "P-Glycoprotein Inhibitors [MoA]",
      "Breast Cancer Resistance Protein Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Alexion Pharmaceuticals Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:25682-046_cd0113b0-d5d6-4b03-9f6f-4d80bdcb71fe"